Generation and expansion of lymphokine-activated killer cells from lymph node lymphocytes in human lung cancer

This publication has 22 references indexed in Scilit:

• Antitumor activity of regional lymph node lymphocytes in patients with lung cancer
  Journal of Surgical Oncology, 1988
• Up‐ and down‐regulation of human lymphokine (IL‐2)‐activated killer cell induction by monocytes, depending on their functional state
  International Journal of Cancer, 1988
• The regulatory effect of adherent cells on lymphokine activated killer cells
  Cellular Immunology, 1987
• A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
  New England Journal of Medicine, 1987
• Interleukin 2 induces proliferation of normal “resting” human T cells in the absence of other known external stimulation
  Cellular Immunology, 1987
• Monocyte‐dependent induction of proliferation of human peripheral T cells by recombinant interleukin 2
  European Journal of Immunology, 1986
• Purification and characterization of recombinant human interleukin-2 produced in Escherichia coli
  Biochemical and Biophysical Research Communications, 1985
• Response of resting human peripheral blood natural killer cells to interleukin 2.
  The Journal of Experimental Medicine, 1984
• Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells
  The Journal of Experimental Medicine, 1983
• Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity
  Journal of Clinical Immunology, 1981